Orthofix Medical INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Orthofix Medical Inc. has issued its 2026 Proxy Statement detailing the upcoming Annual Meeting of Shareholders on June 10, 2026, outlining proposals for director elections, executive compensation, auditor ratification, and stock purchase plan amendments.
NASDAQ
Orthofix Medical Inc. will hold its annual shareholder meeting on June 18, 2025, to vote on director elections, executive compensation, and the ratification of Ernst & Young LLP as the independent auditor.
NASDAQ
Orthofix Medical Inc. will hold its 2025 Annual Meeting of Shareholders on June 18, 2025, to elect directors, approve executive compensation, and ratify the appointment of Ernst & Young as its independent accounting firm.
NASDAQ
DEFA14A: Orthofix Seeks Shareholder Approval for Incentive Plan Amendment to Attract and Retain Talent
Orthofix is requesting shareholder approval to increase the number of shares available under its 2012 Long-Term Incentive Plan by 5,000,000 shares to attract, retain, and motivate employees.
NASDAQ
Orthofix Medical Inc. will hold its annual shareholders meeting on June 19, 2023, with several key proposals up for vote, including the election of directors and amendments to the certificate of incorporation and incentive plans.
NASDAQ
Orthofix Medical Inc. has released its proxy statement detailing proposals for the upcoming 2024 Annual Meeting of Shareholders, including director elections, executive compensation, and amendments to incentive plans.